Search research articles
Contact Us
Filters
Showing results (131-140 of 156) with videos related to
Page
of 16
Sort By:
Molecular Biosystems
|
April 12, 2016
Molecular insight into the differential anti-androgenic activity of resveratrol and its natural analogs: in silico approach to understand biological actions
Sandipan Chakraborty, Avinash Kumar, Nasir A Butt, et al.
Cancer Research
|
September 18, 2001
Molecular classification of estrogens
V C Jordan, J M Schafer, A S Levenson, et al.
Substance Abuse
|
July 11, 2009
Binge drinking and unsafe sex: a study of narcology hospital patients from St. Petersburg, Russia
A Raj, D M Cheng, E M Krupitsky, et al.
The New England Journal of Medicine
|
October 30, 1986
Informed consent by proxy. An issue in research with elderly patients
J W Warren, J Sobal, J H Tenney, et al.
Pharmacoepidemiology and Drug Safety
|
August 24, 2017
Important statistical considerations in the evaluation of post-market studies to assess whether opioids with abuse-deterrent properties result in reduced abuse in the community
Kunthel By, Jana K McAninch, Stephine L Keeton, et al.
FEBS Letters
|
February 24, 2017
MTA1-activated Epi-microRNA-22 regulates E-cadherin and prostate cancer invasiveness
Swati Dhar, Avinash Kumar, Christian R Gomez, et al.
British Journal of Cancer
|
August 15, 2002
Molecular classification of selective oestrogen receptor modulators on the basis of gene expression profiles of breast cancer cells expressing oestrogen receptor alpha
A S Levenson, I L Kliakhandler, K M Svoboda, et al.
Oncotarget
|
March 5, 2016
Dietary pterostilbene is a novel MTA1-targeted chemopreventive and therapeutic agent in prostate cancer
Swati Dhar, Avinash Kumar, Liangfen Zhang, et al.
Plos One
|
March 8, 2013
Pterostilbene acts through metastasis-associated protein 1 to inhibit tumor growth, progression and metastasis in prostate cancer
Kun Li, Steven J Dias, Agnes M Rimando, et al.
Pharmacoepidemiology and Drug Safety
|
June 5, 2013
Use of selective serotonin reuptake inhibitors in pregnancy and cardiac malformations: a propensity-score matched cohort in CPRD
Andrea V Margulis, Adel Abou-Ali, Marian M Strazzeri, et al.
Page
of 16
Search research articles
Search
Showing results (131-140 of 156) with videos related to
Sort By:
Page
of 16
Molecular Biosystems
|
April 12, 2016
Molecular insight into the differential anti-androgenic activity of resveratrol and its natural analogs: in silico approach to understand biological actions
Sandipan Chakraborty, Avinash Kumar, Nasir A Butt, et al.
Cancer Research
|
September 18, 2001
Molecular classification of estrogens
V C Jordan, J M Schafer, A S Levenson, et al.
Substance Abuse
|
July 11, 2009
Binge drinking and unsafe sex: a study of narcology hospital patients from St. Petersburg, Russia
A Raj, D M Cheng, E M Krupitsky, et al.
The New England Journal of Medicine
|
October 30, 1986
Informed consent by proxy. An issue in research with elderly patients
J W Warren, J Sobal, J H Tenney, et al.
Pharmacoepidemiology and Drug Safety
|
August 24, 2017
Important statistical considerations in the evaluation of post-market studies to assess whether opioids with abuse-deterrent properties result in reduced abuse in the community
Kunthel By, Jana K McAninch, Stephine L Keeton, et al.
FEBS Letters
|
February 24, 2017
MTA1-activated Epi-microRNA-22 regulates E-cadherin and prostate cancer invasiveness
Swati Dhar, Avinash Kumar, Christian R Gomez, et al.
British Journal of Cancer
|
August 15, 2002
Molecular classification of selective oestrogen receptor modulators on the basis of gene expression profiles of breast cancer cells expressing oestrogen receptor alpha
A S Levenson, I L Kliakhandler, K M Svoboda, et al.
Oncotarget
|
March 5, 2016
Dietary pterostilbene is a novel MTA1-targeted chemopreventive and therapeutic agent in prostate cancer
Swati Dhar, Avinash Kumar, Liangfen Zhang, et al.
Plos One
|
March 8, 2013
Pterostilbene acts through metastasis-associated protein 1 to inhibit tumor growth, progression and metastasis in prostate cancer
Kun Li, Steven J Dias, Agnes M Rimando, et al.
Pharmacoepidemiology and Drug Safety
|
June 5, 2013
Use of selective serotonin reuptake inhibitors in pregnancy and cardiac malformations: a propensity-score matched cohort in CPRD
Andrea V Margulis, Adel Abou-Ali, Marian M Strazzeri, et al.
Page
of 16